Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 14, 2021; 27(42): 7324-7339
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7324
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7324
Figure 5 Prion protein immuno-gold particles count.
A: Prion protein immuno-gold particles count in whole cells (controls vs pancreatic ductal adenocarcinoma); B: Prion protein immuno-gold particles count in cytosol (controls vs pancreatic ductal adenocarcinoma); C and D: Prion protein immuno-gold particles count in nuclear compartment. A significative difference in prion protein (PrPc) immunogold particles is observed between pancreatic ductal adenocarcinoma (PDAC) and control tissues (C); Even when analyzing the location only in PDAC cells, the nuclear compartment has a significantly higher PrPc concentration (D). aP < 0.0001. Comparisons between two groups were made by using Student t-test. Values are given as the mean ± SD.
- Citation: Bianchini M, Giambelluca MA, Scavuzzo MC, Di Franco G, Guadagni S, Palmeri M, Furbetta N, Gianardi D, Funel N, Ricci C, Gaeta R, Pollina LE, Falcone A, Vivaldi C, Di Candio G, Biagioni F, Busceti CL, Morelli L, Fornai F. Detailing the ultrastructure’s increase of prion protein in pancreatic adenocarcinoma. World J Gastroenterol 2021; 27(42): 7324-7339
- URL: https://www.wjgnet.com/1007-9327/full/v27/i42/7324.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i42.7324